Home › Funds › TRIGLAV INVESTMENTS, D.O.O. › CVS

TRIGLAV INVESTMENTS, D.O.O. position in CVS

CVS Health Corporation · Consumer Staples

TRIGLAV INVESTMENTS, D.O.O. reported holding 112,950 shares of CVS (CVS Health Corporation) in its Q3 2026 13F filing — a position valued at US$9.7M, representing 0.51% of its reported portfolio and ranking #33 among its reported holdings. TRIGLAV INVESTMENTS, D.O.O. has disclosed CVS holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)112.95K sh
Reported value held$9.68M
Portfolio Weight0.51%
First reportedQ4 2024
Last changeHold
Updated2026-11-06

Last updated: 2026-11-06 · Source: SEC EDGAR Form 13F-HR

How TRIGLAV INVESTMENTS, D.O.O.'s CVS position evolved

TRIGLAV INVESTMENTS, D.O.O. first disclosed a stake in CVS in Q4 2024 at 176,080 shares (US$7.9M). The position peaked in Q2 2026 at 112,950 shares, worth US$11.7M. Across 8 filings, TRIGLAV INVESTMENTS, D.O.O. increased the stake 0 time(s), trimmed it 4 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 112,950 shares valued at US$9.7M.

Quarter by quarter

QuarterSharesValueChange
Q4 2024 176.08K $7.90M New
Q1 2025 161.56K $10.95M Reduce
Q2 2025 149.15K $10.29M Reduce
Q3 2025 149.15K $11.24M Hold
Q4 2025 115.95K $9.20M Reduce
Q1 2026 112.95K $8.11M Reduce
Q2 2026 112.95K $11.68M Hold
Q3 2026 112.95K $9.68M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CVS and 13F data

CVS (CVS Health Corporation) is a Consumer Staples company. 39 other funds we track also report a position in CVS — the largest reported positions include Capital World Investors (US$7.75B), Capital World Investors (US$7.75B), Dodge & Cox (US$5.17B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CVS

All CVS fund holders →

FAQ

How long has TRIGLAV INVESTMENTS, D.O.O. held CVS?

TRIGLAV INVESTMENTS, D.O.O. has disclosed CVS holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is TRIGLAV INVESTMENTS, D.O.O.'s current position in CVS?

As of Q3 2026, TRIGLAV INVESTMENTS, D.O.O. holds 112.95K shares of CVS (CVS Health Corporation), valued at $9.68M, representing 0.51% of its reported portfolio and ranking #33.

Has TRIGLAV INVESTMENTS, D.O.O. been buying or selling CVS?

In the latest 13F filing (Q3 2026), TRIGLAV INVESTMENTS, D.O.O. held unchanged its position in CVS. The position peaked in Q2 2026 at 112.95K shares.

Which other funds hold CVS?

Other major institutional holders of CVS include Capital World Investors, Capital World Investors, Dodge & Cox, among 39 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.